News Releases

Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock to $22.5 Million

March 22, 2021

Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock

March 22, 2021

Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy

March 22, 2021

Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian Cancer Vaccine Technology

March 12, 2021

Anixa Biosciences to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

March 8, 2021

Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy

March 4, 2021

Anixa Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference

February 25, 2021

Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates

February 16, 2021

Anixa Biosciences to Present at the B. Riley Oncology Investor Conference

January 13, 2021

Anixa Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference

January 5, 2021

Latest News & Events

Jun 3, 2025

Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview

Read More...

Jun 2, 2025

Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine

Read More...

May 19, 2025

Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones

Read More...